Gilde Healthcare has invested in Tandarts Today
Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.
Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.
Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.
Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.
Ruben Hoefnagels
Founder and CEO, Tandarts Today
Talk to the deal team
Sander van 't Spijker
Oaklins Netherlands
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAcapo AS has been acquired by Longship AS
Oslo-based intellectual property advisory firm Onsagers, supported by Longship since May 2024, has acquired Acapo AS. By combining decades of expertise and global reach, this strategic acquisition unites two of Norway’s most reputable IP firms, enabling them to offer a comprehensive range of solutions in patents, trademarks and IP strategy. This milestone strengthens their position in building a best-in-class network for strategic IP management, marking a key step in their continued growth.
Learn more